07.01.2019 Views

Global IP Matrix - Issue 3 - Jan 2019

Hello & welcome to the third issue of our publication. What a fantastic year it has been for us here at The Global IP Matrix! Firstly, we would like to thank all our clients that have taken the time out of their busy schedules to participate in our magazine this year & more importantly YOU the reader for picking up a copy at the international conferences we have had the pleasure of attending during 2018. We launched The Global IP Matrix at INTA in Seattle, earlier this year and our publication has been going from strength to strength thanks to YOU, our global audience and all our contributors. We have strived to give our readers up to date knowledge on IP issues globally, without pigeonholing our editorial content & focusing on one particular area of intellectual property law. We have persisted with our itinerary & produced some fantastic issues this year that we hope you have enjoyed and will continue to enjoy. We look forward to future issues! Happy New Year, may 2019 be a prosperous new year for you all, From everyone at, Northon’s Media & The Global IP Matrix team.

Hello & welcome to the third issue of our publication. What a fantastic year it has been for us here at The Global IP Matrix! Firstly, we would like to thank all our clients that have taken the time out of their busy schedules to participate in our magazine this year & more importantly YOU the reader for picking up a copy at the international conferences we have had the pleasure of attending during 2018. We launched The Global IP Matrix at INTA in Seattle, earlier this year and our publication has been going from strength to strength thanks to YOU, our global audience and all our contributors. We have strived to give our readers up to date knowledge on IP issues globally, without pigeonholing our editorial content & focusing on one particular area of intellectual property law. We have persisted with our itinerary & produced some fantastic issues this year that we hope you have enjoyed and will continue to enjoy. We look forward to future issues! Happy New Year, may 2019 be a prosperous new year for you all, From everyone at, Northon’s Media & The Global IP Matrix team.

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

www.gipmatrix.com<br />

1


CONTENTS<br />

Page 4<br />

The Knowledge economy:<br />

The future of intellectual property law<br />

Amaka Okafor - Associate (<strong>IP</strong> &<br />

Corporate-Commercial) Stillwaters law firm.<br />

Page 7<br />

Domain names: the difficult combination of <strong>IP</strong> and IT<br />

Bart Mortelmans, from bNamed.net<br />

Page 9<br />

LATVIA – Battles for Domain Names?<br />

Ruta Olmane, Associated Partner, Latvian and European<br />

Trademark and Design Attorney, Lawyer, Metida law firm<br />

(Latvia)<br />

Page 12<br />

Colour Marks in Turkey<br />

Mrs. Pelin Demiroğlu - Attorney at Law, Head of Legal<br />

Affairs, Department Destek Patent<br />

Hello & welcome to the third issue of<br />

our publication…<br />

What a fantastic year it has been for us here at<br />

The <strong>Global</strong> <strong>IP</strong> <strong>Matrix</strong>!<br />

Firstly, we would like to thank all our clients that<br />

have taken the time out of their busy schedules<br />

to participate in our magazine this year & more<br />

importantly YOU the reader for picking up a<br />

copy at the international conferences we have<br />

had the pleasure of attending during 2018.<br />

We launched The <strong>Global</strong> <strong>IP</strong> <strong>Matrix</strong> at INTA<br />

Page 14<br />

EU’s Counterfeit and Piracy Watch-List<br />

Lisa Lovell, CEO & Founder Brand Enforcement UK Ltd<br />

Page 18<br />

Pharma Patents: Healing the Rights<br />

Valery Medvedev, Managing Partner, Russian and<br />

Eurasian Patent Attorney at Gorodissky & Partner<br />

Page 21<br />

Recent amendments to the Patent Act; Argentina<br />

Pablo A. Palazzi, a partner at Allende & Brea<br />

Page 24<br />

Nanobodies – A Patent Landscape Case Study<br />

Ashley Evans – Senior Manager at Patent Seekers Limited<br />

Page 30<br />

Can patent visualisations indicate how patent attorneys’<br />

working environment has changed<br />

by Victor Green, Alessio Brizzi, & Jo Shaw from Victor<br />

Green & Company<br />

in Seattle, earlier this year and our publication<br />

has been going from strength to strength<br />

thanks to YOU, our global audience and all<br />

our contributors. We have strived to give our<br />

readers up to date knowledge on <strong>IP</strong> issues<br />

globally, without pigeonholing our editorial<br />

content & focusing on one particular area of<br />

intellectual property law. We have persisted<br />

with our itinerary & produced some fantastic<br />

issues this year that we hope you have enjoyed<br />

and will continue to enjoy.<br />

We look forward to future issues!<br />

Happy New Year, may <strong>2019</strong> be a prosperous<br />

new year for you all,<br />

From everyone at, Northon’s Media<br />

& The <strong>Global</strong> <strong>IP</strong> <strong>Matrix</strong> team.<br />

Carlos Northon<br />

CEO & Founder Northon’s Media PR &<br />

Marketing LTD<br />

Publisher of The <strong>Global</strong> <strong>IP</strong> <strong>Matrix</strong><br />

carlos@northonsprmarketing.com<br />

Elvin Hassan<br />

Copywriter & Editor<br />

<strong>Global</strong> <strong>IP</strong> <strong>Matrix</strong><br />

Info@northonsprmarketing.com<br />

Craig Barber<br />

Head of design<br />

<strong>Global</strong> <strong>IP</strong> <strong>Matrix</strong><br />

info@northonsprmarketing.com<br />

Marvin Monterola<br />

Head of sales Asia & The Middle East<br />

The <strong>Global</strong> <strong>IP</strong> <strong>Matrix</strong> magazine<br />

marvin.monterola@gipmatrix.com<br />

2 www.gipmatrix.com www.gipmatrix.com<br />

3


THE KNOWLEDGE<br />

ECONOMY:<br />

THE FUTURE OF INTELLECTUAL<br />

PROPERTY LAW<br />

The term ‘knowledge economy/<br />

knowledge-based economy’<br />

was formulated in the 1960s to<br />

describe a shift from traditional<br />

economies which majorly<br />

focused on land, labour, and<br />

capital as factors of production<br />

to one based on information<br />

and innovation (Intellectual<br />

Property/Assets).<br />

An innovation is the creation of a new<br />

product/service or a new process of<br />

creating an existing product/service. As<br />

such, technical advances with respect<br />

to how products are manufactured<br />

or changes in approaches on how<br />

products and services are created,<br />

advertised and sold to the public could<br />

suffice as innovations.<br />

A knowledge economy is accordingly,<br />

an economy which utilizes knowledge<br />

to develop and sustain long-term<br />

economic growth and in which<br />

information, innovation, and goodwill<br />

are considered the most valuable and<br />

expensive assets of the stakeholders.<br />

THE PILLARS OF<br />

THE KNOWLEDGE<br />

ECONOMY<br />

According to the World Bank, a knowledge<br />

economy is primarily supported by four core<br />

pillars:<br />

An adequate “Economic Incentive and<br />

Institutional Regime (EIR)”- this<br />

substantially entails the availability<br />

of sufficient incentives to encourage<br />

entrepreneurship, investments, and<br />

innovations. For a knowledge economy<br />

to thrive in any Jurisdiction, there must<br />

be in place, favourable policies and<br />

regulations to create an environment<br />

that encourages innovation and<br />

investment in the same. Investors and<br />

innovators must know that their rights<br />

and interests are protected for this<br />

economy to thrive.<br />

A functional “Innovation and<br />

Technological Adoption” System- this<br />

relates to having a functional and<br />

<strong>IP</strong> KNOWLEDGE<br />

Amaka Okafor, Associate - Stillwaters Law Firm<br />

www.x stillwaterslaw.com<br />

vibrant network of competent research<br />

centers, firms, consultants, think<br />

tanks, universities, and other similar<br />

organizations working together to<br />

harness the increasing availability<br />

of information, by adapting them to<br />

indigenous needs and inventing new<br />

knowledge and technical solutions.<br />

An effective “Education and Training”<br />

Structure- the success of a knowledge<br />

economy is dependent on a largely<br />

educated and skilled population.<br />

Therefore, adequate education and<br />

training systems must be put in place<br />

for this economy to thrive as it takes<br />

educated and/or skilled manpower to<br />

create, apply and/or share knowledge.<br />

Information and Communications<br />

Technologies (ICT) Infrastructure<br />

and Access- this pillar requires the<br />

availability of effective and dynamic<br />

communication channels ranging from<br />

radio, television to the internet, for<br />

the processing and dissemination of<br />

information 1 .<br />

INTELLECTUAL<br />

PROPERTY(<strong>IP</strong>)<br />

AND KNOWLEDGE<br />

ECONOMY<br />

As explained in the previous section, the<br />

first pillar of a knowledge economy is<br />

the availability of sufficient incentives to<br />

encourage investments. Consequently, one<br />

the most important issues considered by<br />

investors seeking to invest in the Research<br />

and Development (R&D) sector is the extent<br />

to which their investments and resultant<br />

profits can be recuperated; should the R&D<br />

venture result in an innovation. Potential<br />

investors will be unwilling to invest in<br />

R&D which when successful, are unlikely<br />

to be profitable. As a result, establishing a<br />

reliable, effective and enforceable system for<br />

the protection of the rights and interests of<br />

relevant stakeholders in an innovation, is<br />

fundamentally important and indispensable<br />

for the growth of a knowledge economy.<br />

Intellectual Property Laws address this problem<br />

by establishing and conferring enforceable<br />

Intellectual Property rights (<strong>IP</strong> Rights- such<br />

as trademarks, patents, and copyrights) on<br />

innovators and/or investors (as the case may<br />

be) with respect to the innovations. <strong>IP</strong> rights<br />

are basically exclusive rights conferred by the<br />

State on the innovators and/or investors (rights<br />

holders) for the commercial exploitation<br />

of the innovation e.g. trademark, design,<br />

patent, literary and artistic work. These <strong>IP</strong>Rs<br />

are used as leverage by the rights holders to<br />

enter negotiations with third parties who<br />

intend to use or exploit the innovation. These<br />

negotiations are usually in form of licenses<br />

permitting the use of the invention in exchange<br />

for substantial considerations. As a result of<br />

these <strong>IP</strong>Rs, right holders are now capable of<br />

protecting, enforcing and exploiting their<br />

inventions.<br />

The relevance of <strong>IP</strong> rights, both to the rights<br />

holders and consumers, has been clearly<br />

understood with the coming of the internet.<br />

The advent of the internet like never before<br />

brought globalisation of economies and<br />

easy accessibility and replicability of data,<br />

information, and inventions. Stakeholders,<br />

such as manufacturing companies are now<br />

faced with various threats from fraudsters<br />

and counterfeiters trying to freeride on their<br />

investments and goodwill, by replicating<br />

their products which consequently dilutes<br />

their goodwill, creates potential dangers to<br />

consumers (e.g. counterfeit medicines) and<br />

exposes them to unjust liabilities. For this<br />

reason, companies have begun committing<br />

significant resources to the protection of their<br />

intellectual assets.<br />

THE FUTURE OF<br />

INTELLECTUAL<br />

PROPERTY<br />

LAW/RIGHTS<br />

(CONCLUSION)<br />

Previously, the exploitation of natural<br />

resources and adequate manpower were the<br />

primary engines of economic growth. The<br />

world is going digital and so are the economies.<br />

Information is now widely believed to be the<br />

future source of prosperity; representing raw<br />

materials which are transformed using human<br />

intelligence and technology, into innovations<br />

that lead to economic growth.<br />

Nevertheless, for a knowledge economy<br />

to succeed, accessibility to information,<br />

the creation of inventions and effective<br />

management and enforcement of <strong>IP</strong> rights<br />

must be present, working side by side. As<br />

pointed out in preceding paragraphs, any<br />

economy reliant on innovations will not<br />

thrive if there are no reliable incentives for<br />

potential inventors and investors. <strong>IP</strong> laws and<br />

rights create a reliable legal structure for the<br />

investment and commercialisation of <strong>IP</strong> and<br />

accordingly is an indispensable tool in this<br />

economy.<br />

Up until recently, <strong>IP</strong> law, especially in Africa<br />

was a specialised and dehydrated sector of law,<br />

made up of a small group of legal experts and<br />

hardly ever contentious. However, in recent<br />

times and with the development of an economy<br />

based on data and innovations this status<br />

quo has changed significantly. We are now<br />

faced with a new reality where <strong>IP</strong> is created,<br />

encountered and used daily. Furthermore, the<br />

continuous advancement in the use of social<br />

networking platforms and the internet presents<br />

an emerging <strong>IP</strong> market and new challenges for<br />

<strong>IP</strong> regimes.<br />

1- Knowledge Economy Index (KEI) 2012<br />

Rankings<br />

4<br />

www.gipmatrix.com www.gipmatrix.com<br />

5


Domians<br />

Within many corporations,<br />

domain names cause internal<br />

disputes between the ITdepartment<br />

and the legal (or<br />

<strong>IP</strong>) department. Who should<br />

manage this important asset?<br />

The <strong>IP</strong>-department wants to safeguard the<br />

domain names, in order to protect them from<br />

inadvertently expiring or being stolen. They<br />

might even prefer to register the domain<br />

name with the company that also manages<br />

their trademarks. While the IT-department<br />

would want direct control over the technical<br />

settings, to be able to take swift action if an<br />

urgent update is needed. If asked where they<br />

would register a domain name, they’d probably<br />

go for the company that happens to also host<br />

their servers, because of this, domain name<br />

management in many companies is still<br />

scattered.<br />

Domain names are managed by the person<br />

who happened to have been the first one to<br />

ever need that particular domain name. This<br />

causes all sorts of problems, including domain<br />

names being lost simply because the person<br />

who should be looking after it forgot or has<br />

even left the company.<br />

We talked about this with Bart Mortelmans<br />

from bNamed.net. They work on what they<br />

call “domain name outsourcing”. ‘Taking the<br />

burden out of managing a portfolio of domain<br />

names.’ He tells us there are 3 key points that<br />

are important in order to satisfy both IT and<br />

<strong>IP</strong> departments involved: “The first 2 points<br />

are obviously having an interface that caters to<br />

the legal and that offers the features the techies<br />

desire. However, once the two departments<br />

individually are satisfied, to be able to really<br />

talk about outsourcing and getting rid of the<br />

burden, you need to add specialised support<br />

on top of this. One that can talk both “IT”<br />

and “<strong>IP</strong>” and that can connect the two<br />

departments in a way which internally would<br />

not have been possible.”<br />

Domain names:<br />

the difficult combination<br />

of <strong>IP</strong> and IT<br />

Bart Mortelmans, General Manager of Bnamed<br />

www.bnamed.net<br />

However, if a request comes in<br />

via a non-IT department...<br />

Then, they should just as well be able to, at least<br />

set-up the basics of the technical settings. One<br />

way of enabling this is through templates that<br />

can be set-up by a specialist in coordination with<br />

the people managing the servers and that can<br />

then subsequently be selected while requesting<br />

a domain name. However, not every set-up<br />

needs to be so complicated that a template is<br />

needed. Bart Mortelmans tells us how small<br />

changes in the interface can make technically<br />

setting up a domain name a no-brainer for<br />

anybody: “We have been focussing on having<br />

an easy-to-use interface for everybody for<br />

a long time now. For this, in some cases, we<br />

changed how things would normally appear<br />

in a server-control environment. Making<br />

some very small changes<br />

to how things are worded<br />

or in which order they<br />

appear on the screen,<br />

can make a world of a<br />

difference to somebody<br />

not used to the computerlingo<br />

that is most often<br />

used in such interfaces.”<br />

Something else to look<br />

for in such a system is<br />

how helpful it can be<br />

in correcting mistaking<br />

or allowing input<br />

to be automatically<br />

formatted. As you will<br />

know, computers can be<br />

real nitpickers as far as<br />

spaces, dots, quotation<br />

marks or capital letters<br />

are concerned. Having a<br />

system that will autocorrect<br />

this can not only<br />

save you a lot of time<br />

but can actually be a<br />

life-saver for anybody<br />

changing settings for<br />

a domain name that is<br />

already in active use.<br />

‘Outsourcing domain<br />

name management<br />

has not only taken<br />

off with trademark<br />

holders (for which<br />

the service was originally intended) but<br />

also attracted interest from specialised<br />

intellectual property firms:<br />

“We didn’t expect this, but actually there<br />

is a very good reason for this. These <strong>IP</strong>professionals<br />

are confronted with requests<br />

coming from the IT-department of their<br />

clients. So certainly for them, being able to<br />

both get support for the IT-related requests<br />

they get from their clients and being able to<br />

offer their client access to a direct control<br />

panel for all IT-related stuff, is a big asset.<br />

Many trade mark agents are still wary about<br />

also managing domain names, however, with<br />

the right tools and support, this actually<br />

doesn’t need to be any problem.”<br />

Protect your <strong>IP</strong> online<br />

.sg<br />

.com.ar<br />

.sk<br />

.ro .co.nz<br />

.it .bike<br />

.com.au<br />

.si<br />

.lv<br />

.ch<br />

and many more...<br />

.hosting<br />

.dk<br />

.us .brussels .fi<br />

.jp<br />

.pt<br />

.gr<br />

.es<br />

.se<br />

.de .be .net<br />

.cz<br />

.li<br />

.nl .fr<br />

.lt<br />

.lu<br />

.cr<br />

.ru<br />

.ie<br />

.pl<br />

.company .bank<br />

.no<br />

.hr<br />

.fi .ae<br />

.shop<br />

Domain name specialist<br />

since 1999<br />

Every possible extension<br />

.eu<br />

. com<br />

. co m.<br />

br<br />

.uk<br />

Interesting reseller<br />

conditions<br />

Excellent support<br />

T: +44 20 3393 4858 info@bNamed.net<br />

6 www.gipmatrix.com www.gipmatrix.com<br />

7


LATVIA –<br />

Battles for Domain Names?<br />

Ruta Olmane Associated Partner, Latvian and European<br />

Trademark and Design Attorney, Lawyer - www.metida.lt<br />

J. Varbanov & Partners<br />

European and Bulgarian Patent & Trademark Attorneys<br />

One of the oldest and leading <strong>IP</strong> companies in Bulgaria<br />

Professional, cost effective services and quality advices<br />

Areas of practice:<br />

*<strong>IP</strong> Protection<br />

*<strong>IP</strong> Enforcement<br />

*Anti-counterfeiting<br />

*Litigations<br />

*Domain name registrations<br />

*<strong>IP</strong> watches<br />

PO Box 1152, BG-1000 Sofia, Bulgaria<br />

South Park Complex, bl.1A, 2nd fl., BG-1421, Sofia, Bulgaria<br />

Tel.: (+359 2) 986 51 25, Fax: (+359 2) 980 32 47,<br />

e-mail: jvp@jvpatents.com<br />

www.jvpatents.com<br />

Nowadays, if you would like<br />

to look serious in the eyes<br />

of the public, a website with<br />

the correct name or domain<br />

name is a must-have. Many<br />

large companies, as well as<br />

publicly known people, have<br />

done almost the impossible to<br />

protect their virtual identity by<br />

purchasing a range of domain<br />

names with both positive and<br />

negative outcomes.<br />

A domain name is a significant defender of<br />

your company and its brand in the virtual<br />

reality world. Therefore, there are splendid<br />

domain name scammers who will want to earn<br />

at your expense or at your neglect, if you are<br />

not able to reserve the domain names you want<br />

in a timely manner.<br />

Once you state that someone has registered a<br />

domain name which infringes your trademark<br />

rights or company title, you are then expecting<br />

a quick and easy solution for your problem.<br />

However, is it so easy<br />

in Latvia?<br />

So far, it discovers that in Latvia the status<br />

of a domain name and consequently the<br />

procedure in solving disputes about domain<br />

names is demanding more efforts than in other<br />

European Union Member States, especially<br />

if you are comparing it with neighbouring<br />

countries Lithuania and Estonia.<br />

Firstly, the status of country code top-level<br />

domains in Latvia (.lv) is still a subject of many<br />

questions and uncertainties.<br />

In accordance with the Civil Law of the<br />

Republic of Latvia (Articles 927-1129), a<br />

domain name does not embody features<br />

characterising the property, therefore the<br />

domain name is not a property of a natural<br />

person or legal organisation, so you are only<br />

entitled to obtain the rights to use the domain<br />

name. In the meantime, the domain name<br />

in some aspects is considered to be a part of<br />

your intellectual property portfolio and is<br />

thought to be a subject of a certain right as it<br />

is possible to transfer rights to use a domain<br />

name in accordance with a bilateral agreement<br />

or according to a judgement of Court.<br />

From 1993, the Top Level Domain for<br />

Latvia “.lv” and its generic subdomains,<br />

according to the agreement with the <strong>IP</strong>E<br />

(Réseaux <strong>IP</strong> Européens), is administrated<br />

by the Network Information center for<br />

Latvia ((NIC DNS Registry) located in the<br />

Institute of Mathematics and Computer<br />

Science of the University of Latvia). This is<br />

the only competent authority providing the<br />

domain name registration, maintenance,<br />

and administration in Latvia. However, any<br />

dispute arising with respect to domain names<br />

is a subject for judicial review and there is no<br />

administrative institution dealing with these<br />

questions.<br />

General Policies<br />

The general Policies 1 of Registry prescribes<br />

that the domain name shall be chosen in such<br />

a way, so as not to infringe the legitimate rights<br />

of other parties and also not to violate the<br />

existing legislation of the Republic of Latvia.<br />

However, the policies do not contain more<br />

specific rules in respect to a situation when<br />

trademarks or company names are infringed.<br />

One problem – pursuant to personal data<br />

protection and regulation information about<br />

a name, surname and any contact details of<br />

a natural person is not publicly available and<br />

the Register discloses this information only in<br />

accordance with a Court order.<br />

While the Administrative dispute resolution<br />

service (Administrative Panel referred<br />

to in ICANN Uniform Domain Name<br />

Dispute Resolution Policy) for domain<br />

name disputes is not established in<br />

Latvia, all disputes regarding already<br />

assigned domain names are to be<br />

resolved in Civil Court directly between<br />

the current holder of the domain<br />

name and the contesting party<br />

without involvement of the<br />

Registry.<br />

www.gipmatrix.<br />

A cancellation action may be filed under a civil<br />

procedure by a proprietor of a prior trademark<br />

or company name registration and by any<br />

other interested party, if a domain name may<br />

be considered as a generic name (i.e. both on<br />

relative and absolute grounds). In addition,<br />

a cancellation action may be initiated also<br />

if a domain name has been registered and is<br />

being used in bad faith. It is also possible to<br />

request cancellation of a registered domain<br />

name based on unfair competition law if this<br />

domain name is identical with or reproduces a<br />

registered trademark or company name.<br />

After receipt of a judgment of the Civil Court,<br />

a party concerned must submit a judgement<br />

to the Network Information Center for<br />

Latvia (local DNS Registry) and the local<br />

DNS administrator is obliged to immediately<br />

perform any necessary actions concerning<br />

cancellation (deleting) of a domain name from<br />

the database or transferring it to Plaintiff.<br />

As you can see the process itself seems to be<br />

quite simple, nevertheless, there are some<br />

circumstances which might cause several<br />

problems for solving these disputes quickly<br />

and cost-effectively.<br />

9


Ready?<br />

to learn<br />

Set?<br />

to network<br />

Go!<br />

to the world’s<br />

largest <strong>IP</strong> event<br />

Firstly, it is linked with recently adopted rules<br />

for the processing of personal data. Following<br />

these rules, any personal data belonging to the<br />

domain name holder, who is also a natural<br />

person will be removed from the public<br />

register and the Registry will not disclose this<br />

information, otherwise, as only in accordance<br />

with the Court request. Thus, before initiating<br />

any infringement cases you have to conduct<br />

additional action, namely – you have to file<br />

a separate request with the Court asking to<br />

collect the details of the domain name holder.<br />

Secondly, the time and expenses may increase<br />

if the holder of the domain is not from Latvia.<br />

In accordance with the Policies the holder of<br />

the domain name under top level domain .lv<br />

may be:<br />

A commercial entity registered in Latvia<br />

from the moment it is registered in the<br />

Enterprise Registry of the Republic of<br />

Latvia;<br />

A state or local government authority<br />

from the moment it is established;<br />

A foundation, an agency, a union or other<br />

entity established in accordance with the<br />

normative acts of the Republic of Latvia<br />

from the moment it is established;<br />

A natural person, who has reached 18<br />

years of age;<br />

A commercial entity or organization<br />

registered outside the Republic of Latvia<br />

from the moment it is registered.<br />

Thus, there is no limitation that the holder<br />

of the domain name may be a person<br />

from a foreign country.<br />

requirements the Judge has the right to<br />

reject the case, allowing time to consider<br />

more evidence.<br />

The recent case law discovers additional<br />

challenges in disputes about the domain<br />

names and they mostly are related to the<br />

questions about preliminary injunctions.<br />

Preliminary<br />

Injunctions<br />

Firstly, it is necessary to carefully<br />

evaluate whether a requested injunction<br />

is proportionate. Recently, preliminary<br />

injunctions were not granted when the<br />

Plaintiff asked for the locking of the domain<br />

name’s technical data. As blocking access to<br />

the technical data in the Registry database<br />

would result that all services related to a<br />

domain name, such as e-mails, website, and<br />

others would fail to function. Such an outcome<br />

is considered as unproportioned as the merit<br />

of the claim is not reviewed at that moment.<br />

In the meantime, a request to ban the rights to<br />

transfer the domain name is considered as a<br />

reasonable request for preliminary injunctions.<br />

Secondly, the Court raises questions<br />

concerning, whether only the registration<br />

of a certain domain name itself creates an<br />

infringement of trademark rights, as it is not<br />

considered as commercial use of this sign.<br />

In Court, the opinion Plaintiff must prove<br />

that this domain name is used in respect for<br />

identical and/or similar goods and/or services<br />

as a registered trademark or if the Defendant<br />

is performing other commercial activities such<br />

as selling domains etc.<br />

Thirdly, the Register raises questions<br />

concerning, how one proceeds in situations<br />

where the Defendant has not extended an<br />

agreement with the Register for the domain<br />

name in dispute when the dispute (in question)<br />

before the Civil Court is still ongoing.<br />

In accordance with Policy domain names<br />

.lv might be registered only for one year, but<br />

the review of a civil case in Latvia may length<br />

much longer time. Currently, the Court has not<br />

provided any explanation about this question<br />

and it is left on the shoulders of the Plaintiff<br />

to follow the actual situation about the domain<br />

name of his/her interest.<br />

Last but not least, questions are always linked<br />

with the law applicable in the disputes about<br />

country code top-level domains in Latvia (.lv).<br />

As we have no national regulation about these<br />

questions, Plaintiffs and Courts tend to apply<br />

Commission Regulation (EC) No 874/2004 of<br />

28 April 2004, laying down public policy rules<br />

concerning the implementation and functions<br />

of the .eu Top Level Domain and the principles<br />

governing registration, however this is still<br />

quite a disputable practice which leaves a lot of<br />

unanswered questions.<br />

In conclusion<br />

It is noticeable that conflicts between<br />

trademark holders and domain name holders<br />

are becoming more common, also in Latvia.<br />

Currently, the procedure for resolving these<br />

conflicts are expensive and cumbersome,<br />

therefore there is an actual need to adopt more<br />

specific policy rules concerning functions of<br />

the .lv Top Level Domain.<br />

1- The policy for acquisition of the right to use<br />

domain names under the top level domain<br />

.lv, which cover domain name registration<br />

and usage under top level domain .lv and its<br />

generic second level domains (subdomains)<br />

and is an integral part of the agreement.<br />

INTA Annual Meeting<br />

Boston, Massachusetts<br />

May 18–22, <strong>2019</strong> | #INTA<strong>2019</strong><br />

Singapore<br />

April 25–29, 2020 | #INTA2020<br />

Registration opens <strong>Jan</strong>uary <strong>2019</strong>*<br />

INTA members save 30%!<br />

*2020 INTA Singapore Annual Meeting registration opens in <strong>Jan</strong>uary <strong>2019</strong> for INTA members only.<br />

Visit inta.org for more information.<br />

In such cases, following the civil law<br />

provision, the Plaintiff will be obliged to<br />

provide a translation of the claim into the<br />

language which is understandable for the<br />

Defendant and in many cases this language<br />

will not be the English language, but the<br />

official language of the country of which<br />

this person is registered or has an address.<br />

Moreover, following international rules<br />

this claim will then be forwarded to the<br />

Defendant via the Ministry of Foreign<br />

Affairs of Latvia. Therefore, as you can see<br />

this process and such cases take a much<br />

longer time in obtaining a judgement.<br />

Thirdly, you have to take into consideration<br />

that all documents submitted with<br />

the Civil Court in Latvia must<br />

be in an official language or<br />

accompanied by a translation<br />

into the official language of<br />

Latvia, i.e. Latvian language.<br />

Although this is a quite a<br />

formal requirement it should<br />

not be underestimated as in<br />

some cases it creates a lot of<br />

additional expenses. If you<br />

do not comply with these<br />

www.gipmatrix.com<br />

11


TRADEMARKS<br />

Presents<br />

Colour Marks<br />

in Turkey<br />

A colour mark is one of the<br />

non-conventional trademarks<br />

which can uniquely identify the<br />

commercial origin of products<br />

or services in practice, but it is<br />

seen, that cited function is not ‘ex<br />

officio’ accepted by the relevant<br />

authorities.<br />

As a result of the Industrial Property Law<br />

numbered 6769 (“the <strong>IP</strong> Law”) that came<br />

into force on 10 <strong>Jan</strong>uary 2017, the definition<br />

of a trademark has been broadened. The<br />

requirement of capability to be represented<br />

graphically is removed and a clear and<br />

accurate representation in the registry is<br />

found sufficient. Moreover, colours have been<br />

explicitly included in the definition of signs<br />

which shall be protected as a trademark; (Art.<br />

4/1 “… all signs including designs, colours,<br />

numerals, letters, sound and the shape of<br />

goods and their packaging).<br />

§ Quality | Reliable | Invaluable §<br />

Details of the new<br />

definition<br />

When the <strong>IP</strong> Law introduced a new trademark<br />

definition making specific reference to colours,<br />

there was some expectation that registration of<br />

colour marks would become easier. However,<br />

the current acceptance rate for registration of<br />

single-colour marks is 0%. The online Turkish<br />

trademark database lists 46 colour mark<br />

applications and 20 of them, comprising a<br />

single colour, have been rejected. Despite the<br />

recognition of colours as a registrable sign by<br />

the legislator, it is seen that the administrative<br />

authority is (reluctant) to grant protection<br />

for single colours. Both the trademark<br />

Since 1992 ……<br />

YU-LI TSAI<br />

applications comprising<br />

single colours and the<br />

appeals filed against the ex<br />

officio rejection decisions<br />

of the same are being<br />

rejected on the grounds<br />

that the applied trademark<br />

does not have a distinctive<br />

character (Art. 5/1).<br />

It is designated in refusal<br />

decisions that Art. 4/I does<br />

not define that any colour<br />

applied must be registered<br />

as a trademark. Thus,<br />

as can be understood<br />

from the provision of<br />

the relevant article, one<br />

of the basic conditions<br />

required for a sign to be<br />

able to create a brand is<br />

that the sign can be shown<br />

in the registry, so that the<br />

subject of the protection<br />

provided to the trademark<br />

owner can be clearly and<br />

precisely understood from.<br />

The other is the condition<br />

of distinguishing from the<br />

same type of goods and<br />

services offered by other<br />

trademarks. It should<br />

be kept in mind that the<br />

consumers’ perception of<br />

a single-colour mark is not<br />

the same compared to the<br />

12 www.gipmatrix.com<br />

Mrs. Pelin Demiroğlu - Attorney at Law, Head of Legal Affairs<br />

www.destekpatent.com<br />

LU-FA TSAI<br />

<strong>IP</strong> Right Prosecution & Litigation<br />

Corporate Legal & Consulting<br />

<strong>IP</strong> Value-Added Services<br />

Focus: Patents, Trademarks, Copyrights, Trade Secrets, Unfair Competition<br />

Licensing, Counseling, Litigation, Transaction<br />

Territories: Taiwan, Mainland China, Hong Kong, and Macau<br />

Fields: Mechanics, Chemistry, Pharmacy, Biology, Electronics, Optics,<br />

Telecommunications, and Computer Sciences<br />

Address: 13th Floor, 27, Sec. 3, Chung San N. Road, Taipei, Taiwan<br />

Telephone: 886-2-25856688<br />

Fax: 886-2-25989900/25978989<br />

E-mail: email@deepnfar.com.tw<br />

Web site: http://www.deepnfar.com.tw<br />

perception of a word brand, a figurative brand,<br />

or a three-dimensional brand that does not<br />

consist of a product or packaging form. This is<br />

not the case when consumers are accustomed<br />

to recognising brands of distinctive words and/<br />

or shapes as signs that diagnose the product.<br />

The administrative authority also add, that<br />

it is not entirely ignored, that the possibility<br />

that even a single colour in some cases may<br />

be able to distinguish the goods and services<br />

of an entity from the goods and services<br />

of other enterprises. However, in order to<br />

provide a distinctive quality in terms of a<br />

single colour, first of all, the colour should be<br />

used continuously and for a long time on the<br />

relevant product and service and, second of all,<br />

the colour must be perceived as a brand by the<br />

consumers, indicating a certain commercial<br />

resource.<br />

In other words, the authority lets the holders<br />

of the rejected applications apply to the<br />

courts for revocation of the refusal decisions,<br />

claiming that the applied colour marks have<br />

received distinctive character through prior<br />

and frequent use. On the other hand, the<br />

administrative authority can give colour<br />

combinations the green light and decides for<br />

at least the publication of them for third-party<br />

oppositions.<br />

To conclude<br />

It is to be seen what will happen in the future<br />

regarding colour marks. However, it is likely<br />

that the eventual court decisions may reflect a<br />

discomfort, whether the registration of a single<br />

colour grants a monopoly or not.<br />

Arm yourself with<br />

practical solutions<br />

to best navigate the<br />

changing patent<br />

landscape and<br />

maximise the value<br />

potential of your <strong>IP</strong><br />

“Very interesting,<br />

great talks as well as<br />

a great opportunity<br />

to network”<br />

Oil & Gas <strong>IP</strong> <strong>2019</strong>’s Expert Speaking Faculty Includes:<br />

Michel De Puydt<br />

Head of Law Department<br />

– <strong>IP</strong> and Technology<br />

Total S.A.<br />

Charlotta Ljungdahl<br />

VP of Intellectual Property<br />

Air Liquide<br />

Counsel, BP<br />

“Very useful, especially<br />

the networking<br />

aspects”<br />

Head of <strong>IP</strong>, Aker Solutions<br />

Marta Burao Munoz<br />

Director of Technology<br />

Commercialisation & <strong>IP</strong><br />

Repsol<br />

Jalmari Sasi<br />

Senior Legal Counsel<br />

Neste Corporation<br />

Join us at the world's only summit<br />

dedicated to discussing the patent and <strong>IP</strong><br />

issues within the Oil & Gas industry<br />

Dr Geetha Basappa<br />

Senior Patent Engineer<br />

Baker Hughes GE<br />

Hein Wille<br />

Corporate <strong>IP</strong> Director<br />

SBM Offshore<br />

ENQUIRE@IQPC.CO.UK | +44 (0)20 7036 1300 | OILANDGAS<strong>IP</strong>.IQPC.CO.UK<br />

Yuichiro Nakaya<br />

Director of Intellectual<br />

Property<br />

Japanese Oil, Gas &<br />

Metal Corporation<br />

(JOGMEC)<br />

Dr Alta Spamer<br />

<strong>IP</strong> Technical Adviser<br />

Sasol<br />

Hilton Olympia,<br />

London, UK<br />

26th-27th February<br />

<strong>2019</strong><br />

20% off:<br />

<strong>IP</strong><strong>Matrix</strong>20


COUNTERFEIT &<br />

PIRACY<br />

Advertise with us<br />

EU’s Counterfeit and<br />

Piracy Watch-List<br />

Following in the footsteps of the<br />

United States’ Special 301 Report,<br />

the European Commission has<br />

released its first-ever Counterfeit<br />

and Piracy Watch-List. Produced<br />

as part of the Commission’s<br />

complex strategy for the <strong>IP</strong><br />

enforcement, the initiative was<br />

announced in 2017.<br />

The initiative is part of the<br />

Commission’s strategy announced<br />

in the 2017 Communication “A<br />

balanced Intellectual Property<br />

enforcement system responding to<br />

today’s societal challenges”.<br />

The report, published on, 7 December 2018,<br />

which will be updated regularly, identifies<br />

the marketplaces outside the EU where<br />

counterfeiting, piracy or other forms of<br />

intellectual property abuse are common<br />

practice. The report also identifies and<br />

describes the most problematic marketplaces,<br />

with a special focus on online marketplaces.<br />

The report also provides information to EU<br />

rights’ holders on the effectiveness of <strong>IP</strong>R<br />

regimes in countries outside the EU, which<br />

will hopefully enable them to improve their<br />

business strategies and operations to protect<br />

their intellectual property. As a result, it<br />

is hoped that a better understanding will<br />

transpire, as to how to manage risk around <strong>IP</strong>R<br />

when doing business in, or with, certain non-<br />

EU countries.<br />

Intellectual Property<br />

Abuse<br />

The report helps to raise awareness of<br />

consumers that might be buying products<br />

in those marketplaces and encourages their<br />

operators and owners to crack down on<br />

intellectual property abuse:<br />

serious harm to European business<br />

trading outside the European Union<br />

significant economic losses for right<br />

holders and legitimate businesses<br />

undermining of the EU’s comparative<br />

advantages in innovation and creativity<br />

detriment to EU citizens and EU<br />

employees/employers<br />

the risk to consumer health and safety<br />

(i.e. pharmaceuticals, toys, and spare<br />

parts)<br />

harm to the environment (i.e. pesticides)<br />

the risk to consumers of buying substandard<br />

and possibly dangerous goods<br />

consumer risk of buying sub-standard<br />

and possibly dangerous goods<br />

loss of sales/revenues/jobs/government<br />

(i.e. VAT, revenue taxes, customs duties)<br />

damages to brand image and economic<br />

interests of European companies<br />

contribution to organised crime<br />

The “Naughty” List<br />

China<br />

India<br />

Indonesia<br />

(B2C)<br />

Korea<br />

Russia<br />

Thailand<br />

Ukraine<br />

Xxjcy.com / China<br />

Telecommunications<br />

Snapdeal.com<br />

Bukalapak.com<br />

Naver.com<br />

Tiu.ru<br />

Lazada.co.th (B2C)<br />

Prom.ua<br />

Main Complaints by<br />

Stakeholders<br />

The most common complaints by stakeholders<br />

regarding the takedown process are that<br />

there is a distinct lack of co-operation and<br />

communication, erratic implementation<br />

of various different policies, inconsistent,<br />

cumbersome and stringent procedures, lack<br />

of prohibition of prominent keywords which<br />

are often used to search for counterfeit goods,<br />

insufficient or inadequate vetting of sellers, a<br />

lack of proactive measures to detect illegal<br />

listings and unreasonable delays in<br />

processing removals.<br />

Lisa Lovell, CEO of Brand Enforcement UK<br />

www.brandenforcement.co.uk<br />

Co-operation<br />

insufficient cooperation with rightholders<br />

lack of investment in, and use of,<br />

automatic detection technologies<br />

unsatisfactory efforts to reduce the<br />

availability of counterfeits<br />

Communication<br />

total lack of responsiveness by the<br />

respective legal teams<br />

complaints often not acted upon at all<br />

low levels / non-responsiveness to<br />

requests for updates on takedowns<br />

Insufficient information on listing<br />

removals; has it actually been removed<br />

or has it simply expired?<br />

listings frequently left online without<br />

communicating the reason to the<br />

complainant<br />

Implementation<br />

the platform’s policies against <strong>IP</strong><br />

infringements and for the detection and<br />

removal of illegal listings are not properly<br />

implemented<br />

enforcement through the web form has<br />

not resulted in any takedowns<br />

legal team occasionally states that listings<br />

will be removed within 5-7 days, but then<br />

the listing remains live<br />

Inconsistency<br />

complaints handled inconsistently<br />

failure by a seller to remove should =<br />

takedown but there<br />

was a distinct<br />

inconsistency<br />

in action<br />

taken<br />

Reach your target audience of <strong>IP</strong><br />

professionals <strong>Global</strong>ly<br />

3 printed <strong>Issue</strong>s per year.<br />

2K to 2500 prints per issue.<br />

15,000 digital subscribers globally.<br />

3rd party digital distribution internationally for maximum<br />

exposure.<br />

Targeted distribution at 15 international <strong>IP</strong> conferences.<br />

Far more cost effective than our competitors guaranteed.<br />

Contact us at<br />

14 www.gipmatrix.com www.gipmatrix.com<br />

15


Keywords<br />

no prohibition of the use of contentious<br />

keywords in the listings (i.e. “replica”)<br />

no prohibition of terms implying the<br />

products’ counterfeit nature (“A-class” and<br />

“mirror-class” in Korean)<br />

Procedure<br />

unreasonably stringent enforcement<br />

requirements<br />

cumbersome takedown procedure<br />

requiring official complaint with a<br />

physical print out of all infringing URLs<br />

takedown documents must be signed/<br />

stamped/scanned by company<br />

representatives and sent via email for<br />

assessment<br />

Proactiveness<br />

lack of proactive measures to detect illegal<br />

listings<br />

weak system for vetting of sellers<br />

shortcomings with regards to proactive<br />

detection/identification/removal of<br />

counterfeit listings or<br />

no proactive measures employed for<br />

detection or removal<br />

some platforms use image recognition<br />

systems to identify violations but other<br />

automatic technologies are also needed<br />

in order to help analyse and correlate<br />

product, price, and image related<br />

information to flag suspicious listings for<br />

further analysis<br />

Timeliness<br />

unreasonably long processing time for<br />

removals<br />

some sellers allowed up to 5 days to remove<br />

reported listings<br />

The List - An Effective<br />

Tool, to…<br />

raise consumer awareness concerning the<br />

environmental, product safety and other<br />

risks of purchasing on these marketplaces<br />

encourage the operators and owners to<br />

take the necessary actions and measures<br />

to reduce the availability of <strong>IP</strong>R infringing<br />

goods or services<br />

encourage responsible local authorities<br />

and governments to maximise their efforts<br />

to investigate reports of <strong>IP</strong>R infringements<br />

in such marketplaces, and to pursue<br />

appropriate enforcement actions<br />

raise awareness to consumers that might<br />

be buying products in those marketplaces<br />

raise consumer awareness concerning<br />

environmental, product safety and other<br />

risks of purchasing on these marketplaces<br />

thwart the deception of online shoppers<br />

by these e-commerce platforms misusing<br />

such rogue merchants as a marketplaces<br />

urge the owners and operators of these<br />

marketplaces to adopt business models<br />

that rely on the licensed distribution of<br />

legitimate content and products<br />

promote a better partnership between<br />

the owners / operators / right-holders /<br />

enforcement authorities<br />

encourage their operators and owners to<br />

crack down on intellectual property abuse<br />

The commission also proposes to<br />

encourage the specialisation of national<br />

judges for <strong>IP</strong> and the systematic<br />

publication of national judgements in<br />

<strong>IP</strong> enforcement cases and has provided<br />

guidance on existing EU laws.<br />

“With the planned Watch List the<br />

Commission intends to identify<br />

concrete physical and online<br />

marketplaces, located outside the<br />

EU, which engage in or facilitate<br />

<strong>IP</strong> infringements, in particular,<br />

counterfeiting and piracy.”<br />

What did the report<br />

mean for brands?<br />

effective international rules and a solid,<br />

predictable legal system for rights-holders<br />

What the report does not mean for brands?<br />

<strong>IP</strong>R owners cannot expect any immediate<br />

effect from this initiative<br />

ultimate responsibility still on brand<br />

owners to enforce their <strong>IP</strong>Rs worldwide<br />

sole monitoring of online marketplaces is<br />

not enough and other tactics must also be<br />

employed (i.e. Offline Enforcement)<br />

physical factories must be identified,<br />

supply chains made transparent and<br />

physical evidence obtained (i.e. test<br />

purchasing, etc)<br />

E-Commerce<br />

Recommendations<br />

The Recommendations aim in particular at<br />

clearer notice and action procedures and calls<br />

for the following;<br />

more effective tools and proactive<br />

technologies to detect and remove<br />

counterfeit listings and other illegal<br />

content<br />

more transparency on online platforms<br />

closer cooperation with right-holders and<br />

enforcement authorities<br />

more effective measures to detect and<br />

remove counterfeit offers<br />

increased level of cooperation with rightholders<br />

and enforcement authorities<br />

more clarity of the platforms’ terms of<br />

service regarding prohibiting their use<br />

to sell or otherwise trade in counterfeit<br />

goods and services<br />

more effective vetting of the sellers who<br />

are trading on the platforms<br />

more effective automated risk<br />

management tools to identify high-risk<br />

behaviours and potential red flags<br />

The “Nice” List<br />

The following platforms are not listed in EU’s<br />

Counterfeit and Piracy Watch-List.<br />

Aliexpress.com<br />

Amazon.com<br />

eBay.com<br />

Taobao.com<br />

Tmall.com<br />

1688.com<br />

Despite ongoing efforts by Aliexpress,<br />

Amazon, eBay, Taobao, Tmall, and 1688.com,<br />

there is still a significant volume of counterfeit<br />

16 www.gipmatrix.com<br />

goods being offered for sale. On these sites,<br />

however, regards the above-listed e-commerce<br />

platforms, it was also reported that;<br />

a higher level of compliance with<br />

the recommendation on measures to<br />

effectively tackle illegal content online<br />

better cooperation with right-holders<br />

apply both proactive and reactive<br />

measures to detect and remove counterfeit<br />

offers<br />

apply terms of service that include <strong>IP</strong>R<br />

protection policy prohibiting the use of<br />

their platforms to sell counterfeit products<br />

or to provide other infringing services<br />

adopt a number of good practices to<br />

enforce the terms of service vis-à-vis<br />

traders and to cooperate with rightholders,<br />

including tools allowing<br />

right-holders to register their brands,<br />

report counterfeit listings and fast-track<br />

takedown procedures<br />

some platforms also reportedly partner<br />

more closely with brand owners and<br />

content creators to optimise detection<br />

models<br />

some platforms apply different<br />

technological measures seeking to reduce<br />

the availability of counterfeit offers, such<br />

as<br />

automated risk assessment tools<br />

image recognition<br />

semantic recognition algorithms<br />

item-tracing authenticity services to<br />

help consumers verify the authenticity<br />

of products<br />

Further progress is<br />

still required<br />

However, according to stakeholders, further<br />

progress is needed to ensure that offers of<br />

counterfeit products disappear from these<br />

platforms or are significantly reduced<br />

improved trader vetting systems<br />

adoption or improvement of automated<br />

risk management and detection tools<br />

to identify high-risk behaviours and<br />

potential red flags, including dealing with<br />

repeat infringers and suspicious offers<br />

better responsiveness to takedown<br />

requests<br />

more consistency in dealing with similar<br />

cases<br />

increased cooperation with right-holders<br />

(i.e. by simplifying access to the brands’<br />

registers)<br />

The following indicators are not sufficiently<br />

relied on by the platforms when proactively<br />

identifying suspicious listings:<br />

unusual low price level<br />

overly long shipping time<br />

seller history and feedback<br />

lack of pictures of actual products offered<br />

unauthorised use of catalogue pictures<br />

use of pictures that are not showing<br />

labels of the product<br />

an absence of information in the<br />

listing description (often making<br />

it impossible for brand owners<br />

or consumers to determine the<br />

authenticity of the products<br />

An Example of Existing<br />

Best Practice<br />

Real Deal Online Code of Practice http://<br />

www.realdealmarkets.co.uk<br />

The Real Deal Online programme has been designed<br />

to assist administrators of social media selling groups<br />

in discharging their legal responsibilities in relation<br />

to consumer sales by means of their sales group.<br />

The programme requires administrators to liaise<br />

with their local enforcement authorities, to welcome<br />

enforcement officers as members of the group and to<br />

agree to the Real Deal Online Code of Practice, which<br />

comprises just five simple steps:<br />

to prohibit the sale of counterfeit and other illicit<br />

goods<br />

to act on information from <strong>IP</strong>R owners/<br />

representatives reporting the sale of illegal goods<br />

to notify law enforcement if they believe that<br />

illegal goods are being sold within the group and<br />

to exclude the sellers of such goods<br />

to highlight warnings and advice notices posted<br />

by law enforcement<br />

to make sure that all members of the group are<br />

aware of its fake-free policy<br />

“The Watch-List is clearly a step in the right direction,<br />

but we need more collaboration and continued<br />

commitment from all stakeholders to continue<br />

developing best practice methodologies such as the<br />

excellent example set by the UK’s Real Deal Online<br />

Code of Practice” Lisa Lovell, CEO, BEUK.<br />

www.gipmatrix.com<br />

17


Pharma Patents:<br />

Healing the Rights<br />

There isn’t a more valuable asset<br />

than human health but it comes<br />

at a price. Human beings are not<br />

perfect, nature created them in<br />

such a way that they should die<br />

after a time. Permanent attempts<br />

are made by researchers to put<br />

off that time as long as possible.<br />

Researchers devised many<br />

methods to deal with inherent<br />

and acquired human defects,<br />

medicinal preparations being one<br />

of the first choices.<br />

The development<br />

of a new drug is<br />

a sophisticated<br />

process…<br />

Scientists synthesize thousands of substances<br />

that could potentially become medicines.<br />

According to sources, only one of ten thousand<br />

obtained substances reveal properties that<br />

may be useful in treating a disease. After<br />

that preclinical and clinical studies follow,<br />

registration with the health authorities<br />

and finally, the drug goes to the patients.<br />

Pharmaceutical companies spend hundreds<br />

of millions or even billions of US dollars to<br />

find a substance useful for treating a particular<br />

disease. Development of a drug may take ten<br />

years and often more. Sometimes the obtained<br />

drug reveals unexpected properties as occurred<br />

with Viagra which was initially intended to<br />

treat ischemic heart disease but suddenly<br />

revealed other unexpected properties, thanks<br />

to which it became widely known.<br />

It is common knowledge that the development<br />

of efficient drugs involves much effort and<br />

money. Pharmaceutical companies must offset<br />

huge expenses for the development of the drug<br />

and set aside money for future research. For<br />

that purpose, they obtain patents that give<br />

them a lawful monopoly for 20 or even 25<br />

years. Registration of a trademark for the drug<br />

is not a bad idea either which helps to gain<br />

popularity of the drug.<br />

Generic Drugs<br />

Realities of life are such that where there is a<br />

good drug it attracts attention, not only of<br />

practicing doctors but also of the competitive<br />

companies wishing to have their unwelcome<br />

share of the successful drug. These companies<br />

are generally termed as generic companies.<br />

There is nothing bad in the idea itself. Generic<br />

drugs are produced and sold in many countries,<br />

their share being some 50 to 60 percent in a<br />

given market. This, however, is correct in a<br />

situation where the relevant patent has expired<br />

and the company producing the original<br />

drug has had its share of the market and is<br />

working on a drug of the next generation with<br />

improved properties. For example, Humira<br />

(stands for “human monoclonal antibody in<br />

rheumatoid arthritis) used in the treatment of<br />

many ailments needing immunosuppressive<br />

drugs were sold at more than $4000 per month<br />

PATENTS<br />

Valery Medvedev, Managing Partner, Russian and<br />

Eurasian Patent Attorney - www.gorodissky.com<br />

in 2017. After expiry of the patent in Europe in<br />

2018 generic companies were selling the drug<br />

for as little as several hundred USD. The UK<br />

ministry of health plans to save £300 million<br />

on Humira in <strong>2019</strong>.<br />

The problem of generics is also high on the<br />

agenda in Russia. Some generic companies<br />

are reluctant to wait until the patent dies and<br />

initiate production and sales of biosimilars<br />

before the expiration of a relevant patent.<br />

This has really been a headache for original<br />

pharmaceutical companies doing business in<br />

Russia. To a large extent, this is explained by<br />

the absence of patent linkage. The Ministry of<br />

Health does not check whether there is a valid<br />

patent and may issue a marketing authorization<br />

for generic drugs before the expiration of the<br />

relevant patent.<br />

Protection of Drugs<br />

Currently, there are two practically independent<br />

systems of protection of drugs. One concerns<br />

state registration of pharmaceuticals to<br />

prove their safety, efficiency, and quality.<br />

The procedure of registration is regulated by<br />

the Law “On the Circulation of Medicines”.<br />

Another is patent protection endowing the<br />

patent owner with the legal monopoly for the<br />

use of the drug in which the invention is used.<br />

These two systems are independent. Russian<br />

courts recognize that registration of drugs<br />

per se does not infringe patent rights however<br />

patent owners rightly believe that such<br />

registration creates a threat of infringement.<br />

This leads to the situation where a drug covered<br />

by a third party’s patent may be registered<br />

and offered on the market. Only when the<br />

infringing medicine goes to the market the<br />

owner of the patent may sue the infringer,<br />

cancel the registration at the Ministry of<br />

Health and claim damages. The law of many<br />

countries including in one of the members of<br />

the Eurasian Economic Union, Kazakhstan,<br />

provides for the patent linkage. This means<br />

that the applicant for the registration of the<br />

drug should declare that he is not infringing<br />

other persons’ rights while the patent owner<br />

may ask the registration authority to suspend<br />

the registration of the drug.<br />

Russia is hopefully going to change the current<br />

situation and introduce patent linkage too. The<br />

Ministry of Health proposed amending the<br />

Federal law “On the Circulation of Medicines”<br />

related to the submission and examination<br />

of an application for the state registration of<br />

drugs. The bill provides that the pharmaceutical<br />

companies wishing to obtain marketing<br />

authorization should submit information on<br />

the valid Russian patents and trademarks and<br />

confirm that they do not infringe the rights of<br />

other persons.<br />

Compulsory Licenses<br />

The above is not the only hurdle in the business<br />

of pharma. There is another problem standing<br />

in the way of normal pharmaceutical business<br />

in Russia. Several years ago the Federal<br />

Antimonopoly Service (FAS) came up with<br />

a proposal to grant compulsory licenses on<br />

the basis of administrative decision instead<br />

of court. In fact, the concept of a compulsory<br />

license is not new. Compulsory licenses are<br />

provided in the patent laws of many countries<br />

and Russia is not an exception. Article 1362(1)<br />

of the Civil Code (CC) sets forth that if an<br />

invention is not used or used insufficiently<br />

during four years after the grant of a patent<br />

any person may ask the patent owner to issue<br />

a license, and, in case of refusal, sue the patent<br />

owner and obtain a license through the court<br />

judgment. This provision is dormant, however,<br />

not a single license has been granted on the<br />

basis of that article so far. Similar examples<br />

may be cited from other countries: there was<br />

a Bayh-Dole law of 1980 in the US providing<br />

for the grant of compulsory licenses if research<br />

was made with federal funding, however even<br />

in that case no compulsory licenses have been<br />

granted.<br />

While promoting its proposal FAS made<br />

emphasis on Article 1360 CC (the use of an<br />

invention in the interests of national security)<br />

rather than on Article 1362. Article 1360<br />

allows the government to grant permission<br />

for the use of the invention in the interests of<br />

defense and national security. It may be agreed<br />

that in some rare cases national security may<br />

be jeopardized because of insufficient health<br />

care so FAS (or another interested entity) holds<br />

it that a compulsory license could be issued in<br />

certain circumstances.<br />

It seems that prospects of the proposal to<br />

become a law are obscure and are tapering<br />

off to zero. Being disappointed with the dim<br />

prospects of accepting FAS’ proposals some<br />

Russian pharmaceutical companies tackled the<br />

issue from a different angle.<br />

There is a provision in the Civil Code (Article<br />

1362(2)) providing that if the owner of a patent<br />

cannot use his invention without infringing<br />

the rights for another (first) patent and the<br />

owner of that first patent refuses to grant him<br />

a license, the owner of the second patent may<br />

demand a compulsory license from the owner<br />

of the first patent in court.<br />

The owner of the dependent patent when suing<br />

the owner of the original patent should prove<br />

that his invention is an important technical<br />

achievement and has significant economic<br />

advantages over the first invention. If this is<br />

proved the court may grant a compulsory<br />

license.<br />

Proving a significant economic advantage may<br />

not be difficult for the prospective<br />

licensee. He did not spend money<br />

on extensive research and thus<br />

may afford cheaper prices riding<br />

on the findings of the owner of the<br />

original patent.<br />

Important<br />

technical<br />

achievement is a<br />

requirement not<br />

easily defined<br />

Some experts say that in many<br />

cases the results of preclinical<br />

trials of dependent inventions<br />

are not confirmed during clinical<br />

trials. Hence, in order to prove<br />

that the dependent invention is indeed an<br />

important technical achievement, the owners<br />

of such patents should conduct full-scale<br />

clinical trials in order to show advantages over<br />

earlier patents. They prefer not to do that but<br />

simply insist on the alleged importance of<br />

their technical achievement. With that poor<br />

armamentarium, they still go to court but may<br />

be expected to be dismissed. This issue is not<br />

simple.<br />

However when such dependent patent is<br />

obtained by a competitor (presumably unfair)<br />

he and his supporters claim to have made<br />

important technical achievement.<br />

The question arises: how can attempts to use<br />

other people’s inventions, for cheap be offset?<br />

There are several options confirmed by<br />

business and judicial practice. One is to file an<br />

appeal against the grant of a dependent patent<br />

with the Chamber of Patent Disputes of the<br />

patent office. Usually, the ground on which<br />

the appeal can be made is a failure to meet the<br />

“inventive level” requirement.<br />

This seems to be a natural step because such<br />

“secondary” patents, in fact, they slightly<br />

modify the original patents with some<br />

minor modifications without any tangible<br />

improvements. They do not possess better<br />

medical effects nor are they free from negative<br />

side effects. This approach is for the most part<br />

sufficient to have the patent cancelled.<br />

A different approach was demonstrated by<br />

companies in other cases. The holder of a<br />

patent for a dependent invention may obtain<br />

a marketing authorisation while the original<br />

patent is still in force. In this case, the owner<br />

of the original patent may sue the owner of<br />

the dependent patent and claim suspension<br />

or withdrawal of the marketing authorisation.<br />

It is obvious that while the original patent is<br />

not infringed at this stage nonetheless the<br />

marketing authorisation creates a threat for<br />

such infringement. If the dependent patent<br />

owner uses his marketing authorisation and<br />

launches the drug on the market the original<br />

patent owner will have to monitor the market,<br />

collect evidence of infringement and engage in<br />

much more costly court proceedings.<br />

In order to make obtainment of marketing<br />

authorisation impossible, steps are being made<br />

to introduce patent linkage as mentioned<br />

above.<br />

The bottom line: never<br />

Also, there has been a discussion in Russia give up; the stakes are<br />

about “evergreen” patents. When the owner of<br />

the original patent develops its continuation, a too high to ignore the<br />

dependent invention and obtains a patent, he is<br />

sometimes accused of unfair behavior wishing<br />

opportunity to bring false<br />

to extend the validity of his patent to eternity.<br />

“innovators” in line.<br />

18 www.gipmatrix.com www.gipmatrix.com<br />

19


Published by<br />

Northon's Media PR & Marketing Ltd<br />

Recent amendments to the<br />

Patent Act; Argentina<br />

Dedicated to women in Intellectual property Law & Innovation<br />

Recently, Law No. 27.444<br />

introduced a series of<br />

amendments in the Patents<br />

Law. The changes introduced<br />

for patents and utility models<br />

are related to (i) Formal<br />

requirements for filings, (ii)<br />

Substantive examination, (iii)<br />

Priority documents, (iv) Agent<br />

applications, and (v) Deadline<br />

reductions.<br />

The reductions include: (i) for the submission<br />

of third party observations - from 60<br />

business days to 30 calendar days. (ii) For the<br />

conversion of a patent to a utility model - from<br />

90 business days to 30 calendar days. (iii) For<br />

the correction of errors - from 180 days to 30<br />

calendar days.<br />

In particular, the main changes introduced<br />

for patents are related to the deadlines for the<br />

presentation of documentation related to the<br />

patent and the priority document.<br />

Mr Pablo A. Palazzi - Partner at Allende & Brea Argentina<br />

www.allendebrea.com.ar<br />

a certified copy from the original office and<br />

a Spanish version of the submission was in a<br />

different language.<br />

The new regulations intended to make this<br />

optional for trademarks, utility models<br />

and patents, but a new Resolution (N°<br />

250/2018) from the INPI ratified that<br />

this is still mandatory, with exception of<br />

patent submissions. This means that patent<br />

applicants are not required to submit the<br />

priority declaration and the transfer of rights<br />

document (if needed).<br />

In the past, the granting of the patent required<br />

the fees payment, the priority declaration, and<br />

the rights transfer document, among others.<br />

If these documents were not submitted, the<br />

applicant was not able to enjoy the international<br />

priority right. Now, the only documents that<br />

must be submitted are (i) denomination and<br />

description of the invention; (i) plans or<br />

technical drawings which are required for<br />

the comprehension of the description; (iii)<br />

one or more claims and; (iv) a summary of<br />

the invention´s description. In other<br />

words, the requirements were<br />

shortened and simplified.<br />

In addition, the patent act established that<br />

any patent application could be converted<br />

into a utility model application and the other<br />

way round. This conversion could be done<br />

90 days from the filing or during the 90 days<br />

after the Patents Office demands it. However,<br />

the amendments to the patent act shortened<br />

the deadline up to 30 days. As before, if the<br />

applicant does not convert the application<br />

during the deadline established, it shall be<br />

declared as abandoned. This modification<br />

contributes to the aim to speed up the times at<br />

the local Patent Office.<br />

One of the most important amendments<br />

is related to the deadline reduction for the<br />

substantive examination. Previously, the<br />

patent act established a period of 180 days<br />

for the examination, where the applicant<br />

could be required to present any additional<br />

information. In this sense, after the 180 days<br />

period, if the applicant did not comply with<br />

the requirements, the application was declared<br />

as abandoned. From<br />

now on, the<br />

Profiles - Rankings - Achievements - Accolades - Experience - Articles + Much more<br />

Launching at A<strong>IP</strong>PI in London<br />

September 15, <strong>2019</strong> - September 18, <strong>2019</strong><br />

To be involved in this unique publication then, please contact us at<br />

info@worldipwomen.com or call us on +44 (0)208-805-0711<br />

www.worldipwoman.com<br />

Electronic Applications &<br />

what is needed to apply<br />

Previously, the patent act established that in<br />

order to get the patent submitted the applicant<br />

had to file a written application at the Argentine<br />

Patent Office. With the new regulation, this<br />

requirement has been eliminated and Law N°<br />

27.444 only demands “to file an application”.<br />

This means that applications can be made<br />

electronically.<br />

In order to submit a patent application, it is<br />

mandatory to provide the Argentine Patent<br />

Office with information about the applicant<br />

(inventor and company) and the specification,<br />

containing title, description, claims, abstract<br />

and drawings (if any) of the invention.<br />

20 Sponsored www.gipmatrix.com<br />

by PatentSeekers<br />

Regarding the priority right, the patent act<br />

established that priority had to be invoked<br />

at the moment the patent was submitted and<br />

accompanied by a priority declaration with<br />

www.gipmatrix.com<br />

21


SafariRenewals<br />

. . . P r e s e r v i n g Y o u r R i g h t i n A f r i c a<br />

C<br />

M<br />

Y<br />

CM<br />

MY<br />

CY<br />

CMY<br />

K<br />

Safari Renewals LTD is a leading Intellectual Property N<strong>IP</strong>B renewal<br />

company in Africa handling <strong>IP</strong> renewal services in all African<br />

countries Nincluding OAPI and AR<strong>IP</strong>OB+ The company was primarily<br />

established to provide high quality and affordable <strong>IP</strong> maintenance<br />

services to the African community+<br />

Falomo1Ikoyi6 Lagos Nigeria P+O+Box @6464<br />

5078ON3B 738 678 34866O5078ON3B 847 033O@867<br />

renewals@safarirenewals+com<br />

w w w + s a f a r i r e n e w a l s + c o m<br />

applicant has 30 days to comply with any<br />

requirements of the Patent Office during the<br />

substantive examination.<br />

Regarding the substantive examination,<br />

the amendment establishes a maximum<br />

of 18 months for the applicant to pay the<br />

corresponding fees, in contrast with the<br />

previous deadline of 36 months. In this sense,<br />

if the applicant does not pay these fees during<br />

this period of time, the patent application shall<br />

be declared as abandoned.<br />

Changes in Patent<br />

Publications<br />

After the substantive examination, the Patent<br />

Office decides if the patent is granted. Before<br />

these new modifications came into force,<br />

granted patents were published in the patent<br />

office´s Gazette. From now on, they will be<br />

published at the INPI´s website.<br />

Law N° 24.481 established that anyone who<br />

improved a discovery or an invention patent<br />

had the right to request a patent of addition.<br />

However, with the new regulations, only the<br />

ones that improve an invention patent have the<br />

right to request a patent of addition.<br />

In this sense, the actual requirements<br />

for obtaining a patent are:<br />

(i) Language: it is mandatory to submit a<br />

Spanish sworn translation within ten<br />

days from the filing date if the patent is<br />

submitted in a different language.<br />

(ii) Power of attorney: the signature of<br />

the grantor in the power of attorney<br />

must be certified by a Notary Public<br />

and the document must be legalised or<br />

provided with the Apostille of the Hague<br />

Convention in order to be valid.<br />

(iii) Priority Document: the date and priority<br />

number of the original application must<br />

be included on the patent application. A<br />

certified copy from the original may be<br />

requested by the Patent Office during the<br />

substantive examination.<br />

(iv)Substantive examination: the<br />

substantive examination must be<br />

requested and paid within 18 months<br />

from the filing date.<br />

Regarding utility models, the<br />

changes are the following;<br />

Previously, the issue of the certificate of utility<br />

models relied on certain requirements, such<br />

as the invention to be new and with industrial<br />

character. The fact that the invention lacked<br />

inventive activity or had been disclosed abroad<br />

was not an impediment to obtaining the<br />

certificate. This last sentence has been deleted<br />

and the new regulations do not explain<br />

anything about an impediment regarding the<br />

certificate.<br />

Once the applicant files the utility model<br />

application and pays the fee for the substantive<br />

examination, the Patent Office will check if it<br />

complies with the requirements and publish the<br />

application. In this sense, the new regulation<br />

enables a period of 30 days to file oppositions<br />

against applications. Once the 30 days expire<br />

the Patent Office will decide if the application<br />

is granted. However, if the applicant does<br />

not pay the substantive examination fee, the<br />

application will be declared as abandoned.<br />

Utility model applications had to be signed by<br />

the applicant and accompanied by the proof<br />

of payment of the fees. Now, the application<br />

has to comply only with the corresponding<br />

payments in order to avoid the Patent Office to<br />

declare the application null.<br />

In addition, when applications were filed by<br />

legal representatives, it´s personality had to<br />

be properly proven complying with certain<br />

requirements. With the new regulation, the<br />

representation shall be considered as an<br />

affidavit and the Patent Office will be able to<br />

ask for the supporting documentation. In<br />

the case the application is filed by a business<br />

manager, the management shall be ratified<br />

within 40 days after the filing.<br />

When a patent or a utility model was denied,<br />

the applicant had the possibility to appeal in<br />

order to the Patent Office re-consider the denial<br />

of the application or against any observations.<br />

From now, the applicant will be able to file an<br />

administrative appeal against the denial of the<br />

application within 30 days from the denial.<br />

In relation to the funds’ administration, the<br />

INPI has the power to manage the funds raised<br />

from its services and to establish, modify or<br />

delete fees related to the procedures, including<br />

the ones related to the holder´s rights.<br />

Furthermore, the INPI has now the power<br />

to (i) regulate the patents and utility models<br />

procedures, in everything that facilitates them;<br />

(ii) adapt requirements that shall become<br />

obsolete because of new technologies; and<br />

(iii) simplify the registration procedure for the<br />

applicants and the society as a whole.<br />

To conclude<br />

Many of the changes<br />

introduced in the Argentine<br />

Patent Act are welcome and<br />

it is hoped that it will simplify<br />

and shorten the trademark<br />

processes in our country.<br />

Several regulations of the<br />

INPI remain to implement<br />

some of these modifications.<br />

22 www.gipmatrix.com www.gipmatrix.com<br />

23


Nanobodies –<br />

A Patent Landscape Case Study<br />

“Providing insight into current<br />

developments in the Nanobody<br />

Patent Landscape via<br />

statistical analysis conducted<br />

in Questel Patent Portal”.<br />

Mr Ashley Evans – Senior Manager at Patent<br />

Seekers Limited, (Biochemistry BSc) with over<br />

10 years’ experience and biotech subject matter<br />

specialist, the company having completed<br />

more than 15,000 searches for international<br />

patent attorneys both in private practice and<br />

in-house, and for major blue-chip companies –<br />

discusses a patent landscape case study focused<br />

on nanobodies and reveals the key findings<br />

(email: mail@patentseekers.com).<br />

Nanobodies were originally developed from<br />

the discovery that Camelidae (e.g. camels,<br />

etc.) have functional antibodies that<br />

comprise only heavy chains, where the<br />

target recognition module is comprised of<br />

a single variable domain (VHH or Nb) and<br />

two constant domains (CH2, CH3). When<br />

cloned and isolated, the single variable<br />

domains possess full antigen binding<br />

capacity and have excellent stability.<br />

Nanobodies are based on single-domain<br />

antibody fragments and have potential<br />

in an array of diseases, they possess<br />

significant advantages:<br />

-Small size, high solubility, high<br />

stability.<br />

-Highly effective tissue penetration<br />

in vivo.<br />

-Can be linked to Fc-domains,<br />

peptide tags, toxins or other<br />

nanobodies.<br />

-There is the potential for<br />

conjugation at specific sites to drugs,<br />

radionuclides, photosensitizers, and<br />

nanoparticles.<br />

Recombinant production has proven to be<br />

cost-effective and nanobodies may be utilised<br />

as building blocks for multi-domain constructs.<br />

It has been documented that the advantageous<br />

properties of Nanobodies are predominantly<br />

related to their single domain structure,<br />

which is more hydrophilic in comparison with<br />

standard antibody fragments. The Nanobody<br />

surface is convex and the CDR3 loop is<br />

extended, thus enabling effective recognition<br />

of hidden epitopes. Nanobodies are deemed to<br />

Ashley Evans – Senior Manager at Patent Seekers Limited<br />

www.patentseekers.com<br />

be non-immunogenic as a result of high similarity with human VH sequences, they are widely<br />

discussed as very flexible tools, utilised in the fields of research, diagnostics, and therapy.<br />

Whilst research papers offer insight into current scientific research, patent mapping enables the<br />

identification of key trends and information specifically related to the patents in the Nanobody<br />

technology space. This data can be utilised to support business decisions such as focusing areas<br />

of research, planning for current market developments, identifying competitors and supporting<br />

patent filing strategies. The following case study will provide further insight into current<br />

developments in the Nanobody Patent Landscape (2054 patent families identified).<br />

How Rapidly Is New Innovation Taking Place<br />

in This Space?<br />

This graph appears to illustrate that Nanobodies are an accelerating area of technology with<br />

peak activity for the number of filings occurring in recent years since 2015. The apparent dip in<br />

filings in 2017/2018 is most likely explained by applications yet to be published that would be<br />

claiming these years as a priority. The findings may offer an indication that generally assignees<br />

may be building their portfolios. Furthermore, it could be expected that the number of nanobody<br />

related filings may increase further in the coming years as research and development continue<br />

to contribute to the existing trend for greater activity (approximately 28% of the portfolio is<br />

allocated to 2016-17). Note: There will be a gap in current patent information as a result of the<br />

18-month delay between the filing of an application and its publication.<br />

What Is the <strong>Global</strong><br />

Origin of<br />

This Technology?<br />

The distribution of the top twenty priority<br />

countries for this field is shown in the above<br />

map. The map shows priorities originating from<br />

a range of countries across the globe, with a<br />

significant number of patents originating in the<br />

US and China. The next level of distribution<br />

appears to include Europe, Australia, and India.<br />

It should be noted that the map does not show<br />

EPO or WO priorities, there were approx.50%<br />

of families comprising EP application(s) and<br />

approx.72% comprising WO application(s)<br />

within the portfolio. This may indicate that<br />

while the Nanobody technology area has a<br />

relatively global focus with established markets,<br />

there exists further room to expand into new<br />

territories and further develop existing markets<br />

beyond the USA and China.<br />

What Are the Trends<br />

in Technology Focus?<br />

This heat map shows the number of publications<br />

placed in the top twenty <strong>IP</strong>C classifications<br />

over time. As previously discussed nanobodies<br />

are flexible biological tools and as expected the<br />

classification codes identified in this chart reveal<br />

that the portfolio is diversified across a variety<br />

of areas. Since 2016 it appears that the two <strong>IP</strong>C<br />

classifications with the largest distributions are<br />

as follows below, suggesting a therapeutic focus<br />

to the patent portfolio:<br />

A61K39/395 - Medicinal preparations<br />

(comprising Antibodies)<br />

C07K16/28 - Immunoglobulins - against<br />

receptors, cell surface antigens or cell surface<br />

determinants.<br />

What Is the <strong>Global</strong><br />

Grant Success of This<br />

Technology?<br />

The chart above illustrates the proportion of<br />

granted patents to patent applications for the<br />

top twenty most prevalent patenting authorities<br />

in this field. At the time of writing, 49% of the<br />

portfolio is classified as pending, with 37%<br />

classified as granted. This may further indicate<br />

that the Nanobody field is an established yet<br />

growing area. The proportion of granted patents<br />

could be expected to increase in the near future,<br />

should this area of technology keep pace with<br />

the identified trend of an increasing rate of<br />

filings and the high proportion of pending<br />

applications.<br />

24 www.gipmatrix.com www.gipmatrix.com<br />

25


Who Are the Current<br />

Competitors?<br />

The most prevalent assignee appears to be<br />

Ablynx, owning approximately 8% of the<br />

publications in the field and possessing a<br />

strong foothold as the leading company in this<br />

area. Overall, 24% of the portfolio is owned by<br />

the top 10 players who would appear to have<br />

a strong allocation of the Nanobody patent<br />

portfolio. The remaining distribution seems to<br />

be evenly spread over the remaining assignees.<br />

As only three assignees have more than 50<br />

patent families, there are likely many smaller<br />

players in the field.<br />

Technology Landscape<br />

Who Are the Likely<br />

Future Competitors?<br />

The heat map indicates a strong rise in<br />

publications from Novartis over the last<br />

eight years. They face strong competition<br />

from Ablynx who appear to be established<br />

as the market leading Nanobody biotech<br />

company and have consistently invested in<br />

growing their patent portfolio. This chart<br />

enables useful insights into the activities<br />

of competitors and to establish a trend in<br />

terms of which assignees are leading the race<br />

for innovation within this space. It can be<br />

useful to understand the levels of investment<br />

from competing assignees and it may be<br />

beneficial to identify future acquisitions that<br />

could complement an existing <strong>IP</strong> portfolio.<br />

Guangxi and Nanchang Universities are both<br />

recent entries, currently Nanchang is also the<br />

third biggest assignee and based on current<br />

trends, is actively growing its portfolio and<br />

research interests.<br />

What Technologies Are the Top Companies Working On?<br />

This heat map shows the main <strong>IP</strong>C<br />

classifications assigned to the patent portfolios<br />

of the top 20 assignees identified within<br />

the Nanobody dataset. This may enable a<br />

comparison of how diversified or concentrated<br />

the assignee’s portfolio may be. It can provide<br />

an overview of the positioning of applicants<br />

in terms of their research interests or the<br />

identification of any potential complementary<br />

relationships that may exist for collaboration.<br />

It appears that Ablynx has a diversified<br />

patent portfolio with a variety of therapeutic<br />

and diagnostic interests which adds further<br />

weight to its position as a key assignee in the<br />

nanobody field. Using Questel Patent Portal’s<br />

collaboration chart, it was found that there<br />

appears to be collaboration between Novartis<br />

and the University of Pennsylvania, who have<br />

similarly matched patent portfolios based on<br />

the distributions documented above.<br />

This patent map illustrates a set of documents clustered according to their semantic proximity where a<br />

point corresponds to a patent family. The map provides a visualisation of the technology clusters prevalent<br />

within the Nanobody portfolio and reveals a diverse set of interests. The portfolio is predominantly based<br />

on therapeutic patents, with cancer therapy being a hotspot of interest. There also appears to be a variety of<br />

clusters related to the nanobody structure, recombinant technologies, and drug targeting.<br />

To Conclude<br />

This patent landscaping case study has revealed that Nanobody<br />

technology is an established field with trends indicating great<br />

potential for future innovation and patent filings across a diversified<br />

portfolio, comprising a variety of therapeutic and diagnostic related<br />

technology clusters. The landscape has identified a variety of<br />

competitors and their activity levels, including large corporations<br />

such as Novartis, more niche and specialised companies/subsidiaries<br />

such as Ablynx, and a collaborative university presence.<br />

For further insight, specialised state of the art searching could<br />

enable investigation of assignee portfolios or further searching of<br />

more specific Nanobody subject matter. Thus, providing a further<br />

breakdown of inventions that lie within a specific area of the portfolio.<br />

It’s important to understand the limitations (and the errors that can<br />

arise) from this form of statistical based landscape work which is<br />

designed as a guidance tool and to avoid drawing “final” conclusions<br />

such as for infringement/FTO purposes, which requires specialist<br />

searching and analysis. Additionally, there are other charts covering<br />

areas, not within the scope of this article, such as key inventors, key<br />

patents identified from citation analysis and other assignee metrics,<br />

which could also provide useful investigative information relating to<br />

this vibrant and interesting technology area.<br />

26<br />

www.gipmatrix.com<br />

www.gipmatrix.com<br />

27


Specialist global search services for patent attorneys,<br />

universities, technology companies and SME’s<br />

Patentability/Novelty Search<br />

Infringement/FTO/Clearance<br />

Invalidity/Patent Busting<br />

State of the Art<br />

Patent Mapping/Landscapes<br />

Patent Monitoring<br />

Patent Status<br />

Competitor Analysis<br />

Tel: +44 (0)1633 816601<br />

Email: mail@patentseekers.com<br />

www.patentseekers.com


Can patent visualisations indicate how patent attorneys’<br />

working environment<br />

has changed?<br />

At Victor Green & Company we<br />

have been asked to carry out patent<br />

landscape visualisations to provide<br />

analysis, often for broad subject areas.<br />

To show an example of a landscape,<br />

analysts looked at patents and patent<br />

applications that might impact the<br />

working life of patent attorneys. There<br />

are some products on the market that<br />

can create inventions, locate prior<br />

art or file patent specifications. This<br />

article gives an overview of the patent<br />

landscape that may have given rise to<br />

such products.<br />

Background<br />

Some countries, for example, Japan and the<br />

Republic of Korea have considered extending<br />

intellectual property (<strong>IP</strong>) rights to machines<br />

according to Keisner [1]. The European<br />

Parliament recognised the need for legal status<br />

for robots in its Civil Law Rules on Robotics<br />

[2]. Automatic patent drafting was described<br />

by Aristodemou & Tietze [3]. Khoury<br />

considered the use of big data to find prior art<br />

[4]. McLaughlin, Fraser, Hattenbach, and Koza<br />

commented on AI generated inventions [5-8].<br />

Khoury argued that “Human-Like Robots” or<br />

“Hubots” should not be able to obtain <strong>IP</strong> rights<br />

for their inventions [9].<br />

Scope<br />

The aim was for the landscape to give a broad<br />

overview of patent attorneys’ work, to include<br />

anything on data processing that might cross<br />

their desk. If topics were viewed as being<br />

within a patent attorney’s field of expertise,<br />

they were left in the final set, even if they<br />

had not been the focus of the search strategy.<br />

For these reasons, some items were retained,<br />

for example; on patent analysis, databases,<br />

search algorithms, analytical tools, mapping,<br />

translations, and white space analysis.<br />

Some topics were excluded. For example,<br />

blockchain technology relating to <strong>IP</strong> was not<br />

investigated, as it was a substantial topic in its<br />

own right and there were recent reports on this<br />

technology. For this article, it was assumed<br />

that patent attorneys did not spend much time<br />

on patent searching and they obtained searches<br />

from patent analysts. Inventions on patent<br />

searching and retrieval may be covered in more<br />

detail at another time. Generally, references on<br />

trademarks and copyright were left out.<br />

Method<br />

A strategy was devised to retrieve patents and<br />

patent applications on <strong>IP</strong> data processing,<br />

which was run in the PatBase database and<br />

PatBase Analytics module. For further<br />

information about PatBase please see www.<br />

minesoft.com and for an explanation of<br />

strategy construction, see https://www.<br />

victorgreen.co.uk/how_we_search.html.<br />

The strategy started with keywords about<br />

“patents” and “machine filing” in English,<br />

French, German and Spanish and two patent<br />

classification codes. The data processing<br />

subclass (G06Q) from the Cooperative Patent<br />

Classification (CPC) had two subgroups for <strong>IP</strong><br />

management (G06Q50/184) and management<br />

and planning (G06Q10/06), which looked of<br />

interest. Searches revealed further keywords<br />

and classifications which were added to the<br />

strategy e.g. management and automation<br />

(G06Q10/10), marketing and pricing<br />

(G06Q30/02) and finance (G06Q40/06).<br />

Iterative search<br />

improvement and<br />

result filtering<br />

Any additional terms and codes identified<br />

during the search were added to the strategy.<br />

Due to a large number of Asian assignees<br />

in the field, the search was broadened by<br />

adding non-Latin character keywords for<br />

Chinese, Japanese, Korean, for example, 특허<br />

for “patent” in South Korean. The Super<br />

Classification option was used to broaden<br />

the international coverage. This included<br />

Japanese Classification schemes as well as<br />

the Cooperative Patent Classification (CPC),<br />

International Patent Classification (<strong>IP</strong>C) and<br />

the US Patent Classification (USPC).<br />

A ranking of patentees revealed a further CPC<br />

on business transactions (G06Q30/0601).<br />

Generally, the use of classification codes<br />

helped to reduce false drops for terms such<br />

as “patent”, “intellectual property”, “prior art”<br />

and “invention”. These appeared in numerous<br />

specifications to introduce the invention,<br />

without the terms being the subject matter<br />

Victor Green, Founder, Alessio Brizzi & Jo Shaw<br />

www.victorgreen.co.uk<br />

of the invention, for example, “this invention<br />

claims”.<br />

The scope for this article as defined by the<br />

following concept combination searches:<br />

keywords for the “patent” concept<br />

with keywords or classifications for “<strong>IP</strong><br />

management”,<br />

keywords for the “patent” concept<br />

with keywords or classifications for<br />

“management and planning”,<br />

keywords for the “patent” concept with<br />

keywords or classifications for “machine<br />

filing”,<br />

keywords for the “patent” concept with<br />

keywords or classifications for “finance”,<br />

keywords for the “patent” concept with<br />

keywords or classifications for “business<br />

transactions” plus<br />

keywords for the “patent” concept<br />

with keywords or classifications for<br />

“management and automation”.<br />

Results were checked for relevance; irrelevant<br />

records were removed leaving over sixteen<br />

hundred families in the final set, which was<br />

then visualised using PatBase Analytics and<br />

Visual Explorer. The subject matter included<br />

automatic patent filing, computer-generated<br />

inventions, formalities software, reminder<br />

systems for renewal fees, identification of<br />

potential patent infringement, methods for<br />

determining patentability, systems to grant<br />

patents, crowdfunding platforms to<br />

secure <strong>IP</strong>, trading tools, value<br />

assessment<br />

methods,<br />

auctions for<br />

<strong>IP</strong>, prediction<br />

systems, patent<br />

portfolio<br />

management,<br />

business strategy<br />

tools, licensing<br />

arrangements<br />

and information<br />

disclosure statement<br />

management. This<br />

image shows an example<br />

from the results set, of a<br />

method for presenting<br />

patent information.<br />

Fig. 1 Sample image of patent software, US2018089892 from Olaru Gheorghe<br />

Patbase Analytics results<br />

The PatBase Analytics dashboard summary showed that 27% of families had grants. The<br />

jurisdictions graph showed that the US had most filings and most grants. It was followed by<br />

China, South Korea, and Japan. There has been an increase in patent filings from Asia over the<br />

years.<br />

Fig. 2 Top 20 jurisdictions by families, applications and grants<br />

The map view of key filing countries highlighted the US and Asia<br />

Fig. 3 Top 20 jurisdictions by families, applications, and grants<br />

The analysis of<br />

filings showed a<br />

gradual increase<br />

in families filed<br />

since 1999. The<br />

graph shows a<br />

slight acceleration<br />

in filings starting<br />

from the year 2015.<br />

The fall after 2016<br />

is probably to be<br />

ascribed, at least<br />

partially, to the<br />

eighteen months<br />

between priority<br />

and publication.<br />

Fig. 4 Most recent 25 years by families, applications and priority<br />

Conclusion<br />

The areas covered in this landscape<br />

corresponded to some software products<br />

that are available for patent attorneys and<br />

<strong>IP</strong> companies. The inventions aimed to help<br />

attorneys with tasks such as management of<br />

<strong>IP</strong> workflows, the location of prior art and<br />

prosecution of patent specifications. The<br />

analysis showed that the area was fairly young,<br />

with little to no filings prior to the year 2000,<br />

and showed a positive trend in the number<br />

of applications, with an increase after the<br />

year 2015. This was probably due to the fact<br />

that effective, commercially viable products<br />

need to be able to deal with the complexities<br />

that attorneys navigate, and are likely to rely<br />

heavily on the latest advancement in fields<br />

such as machine learning, natural language<br />

processing, and data mining.<br />

Taking into consideration the<br />

above-mentioned findings, and<br />

the limited number of products<br />

currently available on the market,<br />

it would seem that the sector has<br />

not yet matured, but is attracting<br />

increasing commercial interest.<br />

References<br />

1 Keisner CA, Raffo J and Wunsch-Vincent S<br />

Breakthrough technologies – robotics and <strong>IP</strong><br />

W<strong>IP</strong>O Magazine, 6, Dec 2016<br />

2 European Parliaments<br />

Resolution of 16 February 2017 with<br />

recommendations to the Commission on Civil Law<br />

Rules on Robotics (2015/2103(INL))<br />

Strasbourg Final edition, Feb 2017<br />

3 Aristodemou L & Tietze F<br />

The state-of-the-art on Intellectual Property<br />

Analytics (<strong>IP</strong>A): A literature review on artificial<br />

intelligence, machine learning and deep learning<br />

methods for analysing intellectual property (<strong>IP</strong>) data<br />

World Patent Information, Volume 55, Pages 37-51,<br />

Dec 2018<br />

4 Khoury AH & Bekkerman R<br />

Automatic Discovery of Prior Art: Big Data to the<br />

Rescue of the Patent System, 16 J. Marshall Rev.<br />

Intell. Prop. L. 44 (2016)<br />

5 McLaughlin M,<br />

Computer-Generated Inventions<br />

SSRN <strong>Jan</strong> 2018<br />

6 Fraser E<br />

Computers as Inventors – Legal and Policy<br />

Implications of Artificial Intelligence on Patent Law<br />

Scripted, Volume 13, <strong>Issue</strong> 3, Dec 2016<br />

7 Hattenbach B & Glucoft J<br />

Patents in an era of infinite monkeys and artificial<br />

intelligence<br />

STAN.TECH. L.REV. 19, 32 (2015)<br />

8 Koza JR, Keane MA & Streeter MJ<br />

Evolving Inventions<br />

Scientific American 288, 52 – 59, 2003<br />

9 Khoury AH<br />

Intellectual Property Rights for Hubots: On the Legal<br />

Implications of Human-like Robots as Innovators<br />

and Creators<br />

Cardozo Arts & Entertainment Law Journal. Vol. 35<br />

<strong>Issue</strong> 3, p635-668, 2017<br />

30 www.gipmatrix.com www.gipmatrix.com<br />

31


Pakistan Office:<br />

(Adjacent Rado Kronos/Hang Ten Mall Plaza Bldg.)


34 www.gipmatrix.com<br />

NOTES....................................<br />

....................................................................................................................................................................................<br />

....................................................................................................................................................................................<br />

...................................................................................................................................................................................<br />

...............................................................................................................................................................................<br />

...............................................................................................................................................................................<br />

..................................................................................................................................................................................<br />

....................................................................................................................................................................................<br />

....................................................................................................................................................................................<br />

................................................................................................................................................................................<br />

...............................................................................................................................................................................<br />

................................................................................................................................................................................<br />

....................................................................................................................................................................................<br />

....................................................................................................................................................................................<br />

..................................................................................................................................................................................<br />

...............................................................................................................................................................................<br />

...............................................................................................................................................................................<br />

...................................................................................................................................................................................<br />

....................................................................................................................................................................................<br />

....................................................................................................................................................................................<br />

...............................................................................................................................................................................<br />

...............................................................................................................................................................................<br />

.................................................................................................................................................................................<br />

....................................................................................................................................................................................<br />

....................................................................................................................................................................................<br />

.................................................................................................................................................................................<br />

...............................................................................................................................................................................<br />

...............................................................................................................................................................................<br />

....................................................................................................................................................................................<br />

....................................................................................................................................................................................<br />

...................................................................................................................................................................................<br />

...............................................................................................................................................................................<br />

...............................................................................................................................................................................<br />

..................................................................................................................................................................................<br />

....................................................................................................................................................................................<br />

....................................................................................................................................................................................<br />

................................................................................................................................................................................<br />

...............................................................................................................................................................................<br />

................................................................................................................................................................................<br />

....................................................................................................................................................................................<br />

....................................................................................................................................................................................<br />

...........................................................................................<br />

...................................................................................<br />

.....................................................................................<br />

........................................................................................<br />

.................................................................................<br />

..........................................................................................<br />

....................................................................................<br />

....................................................................................<br />

.........................................................................................<br />

.................................................................................<br />

.........................................................................................<br />

.....................................................................................<br />

...................................................................................<br />

..........................................................................................<br />

.................................................................................<br />

........................................................................................<br />

......................................................................................<br />

..................................................................................<br />

...........................................................................................<br />

.................................................................................<br />

.......................................................................................<br />

.......................................................................................<br />

.................................................................................<br />

...........................................................................................<br />

..................................................................................<br />

......................................................................................<br />

........................................................................................<br />

.................................................................................<br />

...........................................................................................<br />

...................................................................................<br />

.....................................................................................<br />

.........................................................................................<br />

.................................................................................<br />

..........................................................................................<br />

....................................................................................<br />

....................................................................................<br />

..........................................................................................<br />

.................................................................................<br />

.........................................................................................<br />

.....................................................................................<br />

...................................................................................<br />

..........................................................................................


Patent information<br />

can be challenging.<br />

Rely on us to help<br />

provide you with<br />

comprehensive,<br />

viable solutions<br />

Our solutions boost efficiency,<br />

without losing accuracy.<br />

• Search patents intuitively and comprehensively with PatBase<br />

• Explore the landscape and turn data into intelligence with<br />

integtrated Analytics V2<br />

• Identify potential licensing opportunities with Citation Explorer<br />

• Monitor competitor’s patents with the comprehensive Legal Status Viewer<br />

Find out how Minesoft solutions can transform the way you work at www.minesoft.com<br />

UK: +44(0)20 8404 0651<br />

DE: +49 (0)211 7495 0930<br />

US: +1 631 459 4786<br />

JP: +81 3 54039191<br />

Lond o n • Dussel d o r f • Washington • To k yo

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!